Inhibitor recurrence after immune tolerance induction: A multicenter retrospective cohort study

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 11, 2015, Pages 1980-1988

  Antun, A ^a   Monahan, P E ^b   Manco Johnson, M J ^c   Callaghan, M U ^d   Kanin, M ^e   Knoll, C ^f   Carpenter, S L ^g   Davis, J A ^h   Guerrera, M F ⁱ   Kruse Jarres, R ^j   Ragni, M V ^k   Witmer, C ^l   Mccracken, C E ^a   Kempton, C L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f PHOENIX CHILDREN'S HOSPITAL   (United States)

^g CHILDREN S MERCY HOSPITAL   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^j TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^l CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

Hemophilia; Immune tolerance; Incidence; Prophylaxis; Recurrence

Indexed keywords

BLOOD CLOTTING FACTOR 8; CISPLATIN; CYCLOPHOSPHAMIDE; HEPATITIS C ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID; RITUXIMAB; ALLOANTIBODY; F8 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT PROTEIN;

ANTIBODY TITER; ARTICLE; BASE PAIRING; BLACK PERSON; CAUCASIAN; CHILD; CHROMOSOME INVERSION; COHORT ANALYSIS; DRUG HALF LIFE; ETHNICITY; FAMILY HISTORY; FEMALE; GENE DELETION; GENOTYPE; HEMOPHILIA A; HISPANIC; HUMAN; IMMUNE TOLERANCE INDUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INCIDENCE; INTRON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; MULTICENTER STUDY; NONSENSE MUTATION; ONSET AGE; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KAPLAN MEIER METHOD; PRESCHOOL CHILD; PROPENSITY SCORE; STATISTICAL MODEL; TIME FACTOR;

CHILD; CHILD, PRESCHOOL; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; ISOANTIBODIES; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MODELS, IMMUNOLOGICAL; PLASMAPHERESIS; PROPENSITY SCORE; RECOMBINANT PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84946554037     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13143     Document Type: Article

References (10)

1. DiMichele DM, Kroner BL. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost 2002; 87: 52-7.
2. Hay CR, DiMichele DM. The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood 2012; 119: 1335-44.
3. Coppola A, Margaglione M, Santagostino E, Rocino A, Grandone E, Mannucci PM, Di Minno G. Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. J Thromb Haemost 2009; 7: 1809-15.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-97.
5. Miller CH, Benson J, Ellingsen D, Driggers J, Payne A, Kelly FM, Soucie JM, Craig Hooper W. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Haemophilia 2012; 18: 375-82.
6. Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, Vehar GA, Capon DJ, Lawn RM. Characterization of the human factor VIII gene. Nature 1984; 312: 326-30.
7. Louviere JJ, Hensher DA, Swait JD. Stated Choice Methods: Analysis and Application. Cambridge, UK: Cambridge University Press, 2000.
8. Mariani G, Kroner B. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success. Haematologica 2001; 86: 1186-93.
9. Bjorkman S, Oh M, Spotts G, Schroth P, Fritsch S, Ewenstein BM, Casey K, Fischer K, Blanchette VS, Collins PW. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight. Blood 2012; 119: 612-8.
10. Collins PW, Mathias M, Hanley J, Keeling D, Keenan R, Laffan M, Perry D, Liesner R. Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort. J Thromb Haemost 2009; 7: 787-94.